Smith, R. E., Reyes, N. J., Khandelwal, P., Schlereth, S. L., Lee, H. S., Masli, S. and Saban, D. R. (2016). Secondary allergic T cell responses are regulated by dendritic cell-derived thrombospondin-1 in the setting of allergic eye disease. J. Leukoc. Biol., 100 (2). S. 371 - 381. BETHESDA: FEDERATION AMER SOC EXP BIOL. ISSN 1938-3673

Full text not available from this repository.

Abstract

Allergic eye disease, as in most forms of atopy, ranges in severity among individuals from immediate hypersensitivity to a severe and debilitating chronic disease. Dendritic cells play a key role in stimulating pathogenic T cells in allergen re-exposure, or secondary responses. However, molecular cues by dendritic cells underpinning allergic T cell response levels and the impact that this control has on consequent severity of allergic disease are poorly understood. Here, we show that a deficiency in thrombospondin-1, a matricellular protein known to affect immune function, has subsequent effects on downstream T cell responses during allergy, as revealed in an established mouse model of allergic eye disease. More specifically, we demonstrate that a thrombospondin-1 deficiency specific to dendritic cells leads to heightened secondary T cell responses and consequent clinical disease. Interestingly, whereas thrombospondin-1-deficient dendritic cells augmented activity of allergen-primed T cells, this increase was not recapitulated with naive T cells in vitro. The role of dendritic cell-derived thrombospondin-1 in regulating secondary allergic T cell responses was confirmed in vivo, as local transfer of thrombospondin-1-sufficient dendritic cells to the ocular mucosa of thrombospondin-1 null hosts prevented the development of augmented secondary T cell responses and heightened allergic eye disease clinical responses. Finally, we demonstrate that topical instillation of thrombospondin-1-derived peptide reduces T cell activity and clinical progression of allergic eye disease. Taken together, this study reveals an important modulatory role of dendritic cell-derived thrombospondin-1 on secondary allergic T cell responses and suggests the possible dysregulation of dendritic cell-derived thrombospondin-1 expression as a factor in allergic eye disease severity.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Smith, R. E.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Reyes, N. J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Khandelwal, P.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schlereth, S. L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lee, H. S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Masli, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Saban, D. R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-268553
DOI: 10.1189/jlb.3A0815-357RR
Journal or Publication Title: J. Leukoc. Biol.
Volume: 100
Number: 2
Page Range: S. 371 - 381
Date: 2016
Publisher: FEDERATION AMER SOC EXP BIOL
Place of Publication: BETHESDA
ISSN: 1938-3673
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
GROWTH-FACTOR-BETA; IMMUNE-MEDIATED BLEPHAROCONJUNCTIVITIS; OCULAR SURFACE INFLAMMATION; VERNAL CONJUNCTIVITIS; IN-VIVO; ATOPIC KERATOCONJUNCTIVITIS; CYTOKINE PRODUCTION; INTERFERON-GAMMA; MURINE MODEL; MAST-CELLSMultiple languages
Cell Biology; Hematology; ImmunologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/26855

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item